ConductScience.org, home

Library / Trials

Inflammation and Medical Provider Attitudes, Cognition, and Treatment Decisions Study

NCT07842367, Phase 2, Recruiting, University of Arkansas, Fayetteville

Trial 10

As registered on ClinicalTrials.gov, in the graph's capture of the registry.

FieldValueSource
TitleInflammation and Medical Provider Attitudes, Cognition, and Treatment Decisions StudyClinicalTrials.gov
NCT numberNCT07842367ClinicalTrials.gov
StatusRecruitingClinicalTrials.gov
PhasesPhase 2ClinicalTrials.gov
Enrollment210 participants, estimatedClinicalTrials.gov
Lead sponsorUniversity of Arkansas, FayettevilleClinicalTrials.gov
ConditionsDecision-Making, Patient Care, Treatment DecisionsClinicalTrials.gov
InterventionsInfluenza vaccine, PlaceboClinicalTrials.gov
First posted2026-09-25ClinicalTrials.gov
Last updated2026-09-30ClinicalTrials.gov

Registered outcomes 6

Each outcome the trial registered, primary first, in ClinicalTrials.gov's words.

ListOutcomeTime frameDescriptionSource
PrimaryTesting Automatic Judgments: "Implicit Association Test"2 daysThis task calculates a "d" score across trials to quantify the strength of implicit associations. Higher d scores indicate more negative automatic attitudes.ClinicalTrials.gov
PrimaryTesting Deliberate Judgments: "Feeling Thermometers"2 daysExplicit attitudes are assessed via 100-point Feeling Thermometers that ask for feeling toward different patient groups. Lower values indicate more negative attitudes.ClinicalTrials.gov
SecondaryQuestionnaire Assessing Social Avoidance: "Patient Sorting Task"1 day
A behavioral decision-making task order patients within an array of three. The three patients are arranged in an order in which the participant would choose to see them. The outcome is the number of trials when a patient from a target group is seen later than a patient from a control group. Higher values indicate greater potential for treatment inconsistencies.
ClinicalTrials.gov
SecondaryQuestionnaire Assessing Perception of Others' Pain: "Threshold for Detecting Pain on Faces"2 days
Participants will see 11 images of targets of different racial groups that have each been morphed to go from no pain to high pain, responding to a yes/no question about whether the target is in pain in each image. The threshold at which participants begin perceiving pain will be calculated for each target and averaged within racial groups. Differences between groups indicate potential for greater treatment inconsistencies.
ClinicalTrials.gov
SecondaryQuestionnaire Assessing Cognitive Depletion: "Stroop Task"2 days
To measure the delay in reaction time between neutral and incongruent stimuli. The task calculates an interference score across many trials to show the difference in response latency between incongruent and congruent trials. Greater interference is a measure of cognitive depletion.
ClinicalTrials.gov
SecondaryQuestionnaire Assessing Motivation: "Motivation to Respond without Prejudice Scale"2 daysIt is administered on a scale of 1 to 9, and the questions are about both internal and external motivation. Higher scores represent more motivation.ClinicalTrials.gov

Outcomes 0

Each outcome the trial posted results for, in ClinicalTrials.gov's words.

TypeOutcomeTime framePopulationUnitsMeasured asSource

Results by group 0

Each measurement the trial posted, group by group, in the words and numbers it posted.

OutcomeGroupCategoryValueSpreadUnitsSource

Participant flow 0

How many started, completed or left each group, period by period.

PeriodMilestoneGroupParticipantsUnits countedSource

Adverse events 0

Each adverse event the trial posted, group by group: the participants affected out of those at risk.

TypeEventOrgan systemGroupAffectedAt riskEventsSource

Adverse event totals 0

The totals the trial posted for each group.

TotalGroupAffectedAt riskSource

Papers 0

The papers the trial lists on ClinicalTrials.gov.

PMIDListed asSource

Grants 1

The grants NIH RePORTER links to the trial, newest funded first: NIH's, and some of AHRQ's, CDC's, FDA's and VA's. Each shows its title, principal investigators, organization and funder in its newest year.

ProjectTitlePrincipal investigatorsOrganizationFunderFiscal yearsSource
R01MD019051The Impacts of Adverse Provider Conditions on Provider Bias and Health DisparitiesMAKHANOVA, ANASTASIAUNIVERSITY OF ARKANSAS AT FAYETTEVILLENATIONAL INSTITUTE ON MINORITY HEALTH AND HEALTH DISPARITIES2024 to 2025NIH RePORTER

Trial comparisons 0

Comparisons of the trial's two groups, calculated by ConductScience from the counts it posted.

ComparisonSource

Tests 2

The ConductCognition tests this trial's registered outcomes name, as ScienceGraph matched them in trial-tests-2026-11-12-0.2.1.

TestNamed asSource
Implicit Association Test (IAT)Primary outcomeConductCognition
Stroop Color-Word TestSecondary outcomeConductCognition

Source 5

FieldValueSource
Releasetrials-2026-11-12-0.4.0ClinicalTrials.gov
Release manifest SHA-2560f4a8d8c48aee2a7573ae0fa94ecbeab70c1adbe449bbc95c424bc7d3e97b9d4ClinicalTrials.gov
Registry capture2026-11-12ClinicalTrials.gov
Results copy, AACT2026-03-23ClinicalTrials.gov
NIH clinical studies file2026-11-13ClinicalTrials.gov

The same record as JSON

Release trials-2026-11-12-0.4.0

ClinicalTrials.gov's posted results, through CTTI's AACT: ClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299 ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

ClinicalTrials.gov: none stated ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

NIH RePORTER's clinical studies and project files: Public domain (NIH RePORTER)